Nick Dearden

Helena, a political commentator known as NoJusticeMTG, joins Nick Dearden, director of Global Justice Now, and economist James Meadway for an insightful discussion. They explore the implications of rising drug prices in the UK due to pressures from Trump's policies. Helena warns about the erosion of public sector skills by AI and consultancies, while Dearden advocates for public funding in pharmaceuticals. Meadway raises alarms over the potential economic fallout from an AI valuation collapse, linking it to broader financial risks.

Nick Dearden, author of PharmaNomics, and Phil Whitaker, a seasoned NHS GP, dive into the murky waters of Big Pharma's influence on healthcare. They discuss how pharmaceutical companies have historically manipulated doctors and the regulatory environment to prioritize profits. The dark legacy of OxyContin marketing reveals the dangerous consequences of profit-driven strategies. Dearden and Whitaker also advocate for rethinking pharmaceutical regulations, emphasizing the need for public interest over corporate profit, inspired by innovative models from countries like South Africa.

Join Nick Dearden, director of Global Justice Now, who sheds light on international trade and his book, Pharmonomics. Maria Finnerty, lead economist at CAFOD, discusses the pressing issues of global debt justice. Kojo Koram, a law reader at Birkbeck College and author of Uncommon Wealth, analyzes the challenges facing neoliberalism today. The trio delves into the impacts of Trump's presidency on global trade dynamics, the urgent need for equitable policies, and the role of grassroots movements in shaping a sustainable future.